Citadel Advisors’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79.3M Buy
2,241,584
+1,043,316
+87% +$32.4M 0.01% 982
2025
Q4
$33.5M Buy
1,198,268
+493,434
+70% +$14.8M 0.01% 1801
2025
Q3
$21.1M Buy
704,834
+667,411
+1,783% +$18.8M ﹤0.01% 2258
2025
Q2
$1.07M Sell
37,423
-46,944
-56% -$1.4M ﹤0.01% 6938
2025
Q1
$2.79M Buy
84,367
+31,161
+59% +$1.02M ﹤0.01% 4898
2024
Q4
$1.53M Sell
53,206
-29,718
-36% -$854K ﹤0.01% 6188
2024
Q3
$2.32M Sell
82,924
-239,290
-74% -$6.38M ﹤0.01% 5255
2024
Q2
$7.77M Buy
322,214
+267,931
+494% +$6.57M ﹤0.01% 3120
2024
Q1
$1.47M Buy
+54,283
New +$1.54M ﹤0.01% 6130
2023
Q4
Sell
-378,762
Closed -$9.84M 14207
2023
Q3
$10.6M Sell
378,762
-1,102,707
-74% -$32.3M ﹤0.01% 2619
2023
Q2
$46.4M Sell
1,481,469
-2,003,150
-57% -$60.7M 0.01% 1111
2023
Q1
$98.2M Sell
3,484,619
-2,943,669
-46% -$80.2M 0.02% 622
2022
Q4
$168M Buy
6,428,288
+2,746,011
+75% +$65.7M 0.04% 396
2022
Q3
$82.2M Buy
3,682,277
+899,970
+32% +$23.4M 0.02% 714
2022
Q2
$82.9M Buy
2,782,307
+439,328
+19% +$12.6M 0.02% 677
2022
Q1
$61.6M Buy
2,342,979
+1,684,879
+256% +$41.7M 0.01% 970
2021
Q4
$15.3M Buy
658,100
+104,142
+19% +$2.74M ﹤0.01% 2384
2021
Q3
$17.1M Buy
553,958
+291,038
+111% +$8.22M ﹤0.01% 2232
2021
Q2
$6.45M Sell
262,920
-48,822
-16% -$1.09M ﹤0.01% 3908
2021
Q1
$5.82M Buy
311,742
+169,049
+118% +$3.46M ﹤0.01% 3930
2020
Q4
$2.85M Buy
142,693
+63,275
+80% +$1.16M ﹤0.01% 4664
2020
Q3
$1.32M Buy
79,418
+38,333
+93% +$697K ﹤0.01% 5525
2020
Q2
$797K Sell
41,085
-596,063
-94% -$9.68M ﹤0.01% 6245
2020
Q1
$9.19M Sell
637,148
-308,443
-33% -$5.51M ﹤0.01% 1948
2019
Q4
$19.3M Sell
945,591
-349,786
-27% -$6.95M 0.01% 1519
2019
Q3
$25.3M Buy
1,295,377
+755,854
+140% +$16.4M 0.01% 1266
2019
Q2
$12.2M Buy
539,523
+427,099
+380% +$11.7M 0.01% 1940
2019
Q1
$4.1M Sell
112,424
-123,083
-52% -$4.06M ﹤0.01% 3275
2018
Q4
$6.95M Buy
235,507
+149,798
+175% +$5.52M ﹤0.01% 2336
2018
Q3
$3.64M Sell
85,709
-153,734
-64% -$6.67M ﹤0.01% 3438
2018
Q2
$9.86M Buy
239,443
+161,671
+208% +$7.36M ﹤0.01% 1949
2018
Q1
$4.51M Buy
+77,772
New +$4.55M ﹤0.01% 2580
2017
Q2
Sell
-312,083
Closed -$18.1M 7419
2017
Q1
$18.3M Buy
312,083
+298,918
+2,271% +$17M 0.02% 1030
2016
Q4
$732K Buy
+13,165
New +$704K ﹤0.01% 4318
2016
Q3
Sell
-876,823
Closed -$41.7M 7185
2016
Q2
$37.9M Buy
+876,823
New +$36.2M 0.04% 462
2016
Q1
Sell
-996,443
Closed -$39.4M 6673
2015
Q4
$79.1M Sell
996,443
-457,595
-31% -$32M 0.09% 247
2015
Q3
$85.3M Buy
1,454,038
+179,956
+14% +$11.9M 0.08% 242
2015
Q2
$82M Buy
1,274,082
+680,580
+115% +$41.6M 0.07% 297
2015
Q1
$36.2M Buy
593,502
+494,360
+499% +$33.8M 0.03% 637
2014
Q4
$5.81M Buy
99,142
+80,835
+442% +$4.12M 0.01% 1839
2014
Q3
$785K Sell
18,307
-112,427
-86% -$5.04M ﹤0.01% 4022
2014
Q2
$6.58M Buy
130,734
+109,986
+530% +$5.07M 0.01% 1609
2014
Q1
$915K Buy
20,748
+18,727
+927% +$891K ﹤0.01% 3537
2013
Q4
$82K Sell
2,021
-123,240
-98% -$4.55M ﹤0.01% 5756
2013
Q3
$4.21M Sell
125,261
-75,743
-38% -$2.47M 0.01% 1709
2013
Q2
$5.76M Buy
+201,004
New +$5.86M 0.01% 1448

Other funds holding ALKS

Citadel Advisors's ALKS Position: Q1 2026 in Review

Citadel Advisors increased its Alkermes (ALKS) stake by 87% in Q1 2026, buying an estimated $32.4M and bringing the position to 2,241,584 shares worth $79.3M. The position accounts for 0.01% of the portfolio, ranked #982.

Citadel Advisors first reported a position in ALKS in Q2 2013 and has held it in 46 quarters since. The position peaked at $168M in Q4 2022. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Citadel Advisors held 2,241,584 shares of Alkermes worth $79.3M as of Q1 2026.
  • Citadel Advisors bought 1,043,316 Alkermes shares in Q1 2026, an estimated $32.4M.
  • Alkermes made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #982 holding.
  • Citadel Advisors first reported a position in Alkermes in Q2 2013 and has held it in 46 quarters since.
  • Citadel Advisors's Alkermes position peaked at $168M in Q4 2022.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.